Research and Markets: Global Myocardial Infarction Pipeline Review 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/dth377/myocardial) has announced the addition of the "Myocardial Infarction - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Myocardial Infarction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myocardial Infarction and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Alligator Bioscience AB
  • AstraZeneca PLC
  • Athersys, Inc.
  • Bayer AG
  • CellProthera
  • Compugen Ltd.
  • CSL Limited
  • FibroGen, Inc.
  • Fina Biotech
  • Genextra S.p.a.
  • GlaxoSmithKline plc
  • GliaMed, Inc.
  • Hadasit Medical Research Services & Development Ltd
  • Lacer, S.A.
  • Lee's Pharmaceutical Holdings Limited
  • LegoChem Biosciences, Inc
  • LG Life Sciences, Ltd.
  • Ligand Pharmaceuticals, Inc.
  • Medestea Research & Production S.p.A.
  • Merck & Co., Inc.
  • Omni Bio Pharmaceutical Inc.
  • Pluristem Therapeutics Inc.
  • Polyphor Ltd.
  • Quantum Genomics SA
  • Recardio GmbH
  • Remedy Pharmaceuticals, Inc.
  • Targazyme, Inc.
  • Vicore Pharma AB
  • Zydus Cadila Healthcare Limited

For more information visit http://www.researchandmarkets.com/research/dth377/myocardial

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular